What is the current price of Eli Lilly stock on the Swiss Exchange?

As of now, Eli Lilly's stock on the Swiss Exchange is priced at CHF870.0 per share, showing no change from its previous close of CHF870.0. The stock remains stable despite low daily volume.

How do Eli Lilly's technical indicators inform trading decisions?

Technical indicators like an RSI of 74.95 suggest an overbought status, while the MACD and ADX highlight a strong upward trend. Each indicator provides insights for potential future price movements.

What financial strengths does Eli Lilly possess?

Eli Lilly showcases a strong net profit margin of 30.99% and return on equity of 102.26%, indicating high profitability and efficient use of equity capital.

How does Eli Lilly's sector influence its performance?

Operating within the healthcare sector, Eli Lilly benefits from ongoing demand for pharmaceuticals and a competitive edge through partnerships and innovations, aligning with industry growth trends.

When is the next earnings announcement for Eli Lilly?

Eli Lilly's next earnings announcement is scheduled for February 4, 2026, at 13:30 GMT, providing insights into the company’s continued financial health.

CH Stocks

Eli Lilly’s Swiss Trading Update: Examining the Metrics

ByHuzaifa Zahoor December 1, 2025

Eli Lilly and Company’s stock, trading under LLY.SW on the Swiss Exchange, currently maintains a steady price of CHF870.0. Despite stable daily figures, year-over-year changes highlight notable growth, positioning Eli Lilly as a significant player within the healthcare sector. This article delves into key metrics, recent performance, and analyst expectations for this major pharmaceutical company.